Edward Tenthoff

Why Moderna Shares Are Rebounding From Friday's Losses

Moderna Puts Its First Seasonal Flu Vaccine In The Clinic

Moderna Analyst Says Biotech Has 'First-To-Market' Potential For Coronavirus Vaccine

Moderna Puts Its First Seasonal Flu Vaccine In The Clinic

Moderna Analyst Says Biotech Has 'First-To-Market' Potential For Coronavirus Vaccine

Analysts React To Arrowhead's Janssen Collaboration: Downside In Stock May Be 'Misguided'

PiperJaffray, Stifel Defend Array Biopharma As Stock Falls On Profit-Taking

Analysts React To Arrowhead's Janssen Collaboration: Downside In Stock May Be 'Misguided'

PiperJaffray, Stifel Defend Array Biopharma As Stock Falls On Profit-Taking

Why Investors Should Take Another Look At Alnylam Pharmaceuticals

The Search For Silver Linings In The Cloud Of Negative Novavax News

Edward Tenthoff Recent News

'We're Confident Arrowhead's ARC-520 Is Active Drug For HBV,' Piper Jaffray Says

4 Biotechs Piper Jaffray Is Buying On The Pullback

Baird And Piper Jaffray Love Vertex: Here's Why

UPDATE: Piper Jaffray Downgrades Trius Therapeutics Following Cubist Acquisition

UPDATE: Piper Jaffray Downgrades ISIS Pharmaceuticals on Limited Ownership of Pipeline

UPDATE: Piper Jaffray Downgrades Omthera Pharmaceuticals to Neutral on AstraZeneca Acquisition

Vivus Tumbles 70% on FDA Disapproval; Piper Jaffray Urges You to Buy Arena (ARNA, VVUS)

Piper Jaffray Impressed By New Regeneron Drugs (REGN)

Cytori Therapeutics (NASDAQ: CYTX) Shares Fall On News Of Launch Delay